Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Affordable in-house antiretroviral drug resistance assay with good performance in non-subtype B HIV-1.

Journal of virological methods - 1 Feb 2010

Wallis Carole L, Papathanasopoulos Maria A, Lakhi Shabir, Karita Etienne, Kamali Anatoli, Kaleebu Pontiano, Sanders Eduard, Anzala Omu, Bekker Linda-Gail, Stevens Gwynn, de Wit Tobias F Rinke, Stevens Wendy

Abstract excerpt

The introduction of antiretroviral (ARV) therapy in resource-poor settings is effective in suppressing HIV-1 replication and prolonging life of infected individuals. This has led to a demand for affordable HIV-1 drug resistance assays, since treatment failure due to development of drug resistance is common. This study developed and evaluated an affordable "in-house" genotyping assay to monitor HIV-1 drug...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Retroviral Agents
Share to Automation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to Genes, Viral

Share to RNA, Viral

Share to Sensitivity and Specificity

Share to South Africa

Source

Open in PubMed Open full text

Identifiers

PMID: 19917318
DOI: 10.1016/j.jviromet.2009.11.011
PMCID: PMC2932961

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Affordable in-house antiretroviral drug resistance assay with good performance in non-subtype B HIV-1.PMID 19917318Read ↗

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited SettingsSemantic proximity Read ↗

Evaluation of a cost effective in-house method for HIV-1 drug resistance genotyping using plasma samples.Semantic proximity Read ↗

Optimization of a low cost and broadly sensitive genotyping assay for HIV-1 drug resistance surveillance and monitoring in resource-limited settings.Semantic proximity Read ↗

Evaluation of a Novel In-house HIV-1 Genotype Drug Resistance Assay using Clinical Samples in China.Semantic proximity Read ↗

Evaluation of an in-house genotyping resistance test for HIV-1 drug resistance interpretation and genotyping.Semantic proximity Read ↗

A simple and sensitive 'in-house' method for determining genotypic drug resistance in HIV-1.Semantic proximity Read ↗

Evaluations of an in-house drug resistance method for HIV-1 drug resistance using ViroSeq™ 2.0 genotyping system as a gold standard.Semantic proximity Read ↗

Field evaluation of a broadly sensitive HIV-1 in-house genotyping assay for use with both plasma and dried blood spot specimens in a resource-limited country.Semantic proximity Read ↗

Update on HIV-1 acquired and transmitted drug resistance in Africa.Semantic proximity Read ↗

Affordable HIV drug-resistance testing for monitoring of antiretroviral therapy in sub-Saharan Africa.Semantic proximity Read ↗

Evaluation of two commercial kits for the detection of genotypic drug resistance on a panel of HIV type 1 subtypes A through J.Semantic proximity Read ↗

[The study of an in-house method for drug resistance genotyping testing on HIV-1 strains prevailing in China].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.